BridgeMD
New treatment option for Orofacial Myofunctional Disorders
Official title Oral Myofunctional Pattern in Children With Anterior Open Bite
ClinicalTrials.gov ID: NCT07045779
What this study is testing
- What it's testing
- Oral myofunctional disorders (OMD) are a key, internationally acknowledged environmental factor causing dental and skeletal malocclusion. For the past 15 years, research regarding the efficacy of orofacial myofunctional therapy (OMT) to reduce OMD and to contribute to the treatment of malocclusions has been significantly increased.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 12
You may be able to join if
- Presence of anterior open bite (AOB)
- Early or intermediate mixed dentition phase
You likely can't join if
- History of or active engagement in orofacial myofunctional therapy (OMT)
- History of or active engagement in orthodontic therapy
- Congenital abnormalities, syndromes, or surgical needs affecting the oral and maxillofacial region
- Disorders affecting motor or cognitive development
- Current or recent (\< 3 months) non-nutritive sucking habits
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 12 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.